Wellinks raises $10.0M Series B (United States, Aug 2026)
Reach the investors backing rounds like this
Backed by UMass Memorial Health, inside investors · verified emails and LinkedIn on Datapile
Wellinks Closed $10 Million Series B Funding | Function Secures $450 Million Growth Financing - Healthcare IT Today
Wellinks is a leader in cardiopulmonary care, focusing on predictive care solutions for chronic respiratory diseases. The company aims to expand patient access to its FDA-cleared Spire Remote Patient Monitoring System, which helps identify early physiologic changes associated with clinical deterioration.
Wellinks Closed $10 Million Series B Funding | Function Secures $450 Million Growth Financing Healthcare IT Today
| Oct 08, 2026 | Natron Energy | $10.2M | — | United States |
| Oct 08, 2026 | Hone | $60.0M | Seed | United States |
| Oct 08, 2026 | Arena | $200.0M | Series B | United States |
| Oct 08, 2026 | Quaise Energy | $25.0M | Grant | United States |
21,999 investors back startups in United States
You just read who funded Wellinks. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.